Dergiler / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 5

The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey

Sayfa
546–552
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Logistic regression analysis showed that significant predictors of insulin resistance were high alanine transaminase levels (odds ratio, 0.97; 95% confidence interval, 0.944-0.997) and liver fibrosis stage (odds ratio, 0.114; 95% confidence interval, 0.0210.607).Conclusion: Our findings revealed significant associations between insulin resistance and hepatic fibrosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: To evaluate the association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C.Materials and Methods: A total of 104 chronic hepatitis C patients were included in this non-interventional, openlabel, observational, multicenter, cross-sectional study conducted at 20 gastroenterology clinics in Turkey.
📊
Temel Bulgular & Veri:Results: The mean age of patients was 52.8 years; 65.4% were female.
💡
Sonuç & Katkı:Logistic regression analysis showed that significant predictors of insulin resistance were high alanine transaminase levels (odds ratio, 0.97; 95% confidence interval, 0.944-0.997) and liver fibrosis stage (odds ratio, 0.114; 95% confidence interval, 0.0210.607).Conclusion: Our findings revealed significant associations between insulin resistance and hepatic fibrosis.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: To evaluate the association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C.Materials and Methods: A total of 104 chronic hepatitis C patients were included in this non-interventional, openlabel, observational, multicenter, cross-sectional study conducted at 20 gastroenterology clinics in Turkey. The primary end point was the correlation between stage of hepatic fibrosis and insulin resistance evaluated via the homeostasis model of assessment-insulin resistance index. Confounders of hepatic fibrosis and insulin resistance were the secondary end points. Results: The mean age of patients was 52.8 years; 65.4% were female. Type 2 diabetes was present in 6.8% and insulin resistance noted in 38.0% of patients. Further, 45.7% of the patients had mild (A0/A1) and the remaining had moderate/severe (A2/A3) hepatic necroinflammatory activity. Patient distribution according to Metavir fibrosis stage was as follows: F0/F1 (57.0%); F2 (6.5%); F3 (23.7%); and F4 (12.9%). A univariate analysis revealed significant positive correlations between Metavir fibrosis stage and insulin resistance (r=0.297; p=0.007). Logistic regression analysis showed that significant predictors of insulin resistance were high alanine transaminase levels (odds ratio, 0.97; 95% confidence interval, 0.944-0.997) and liver fibrosis stage (odds ratio, 0.114; 95% confidence interval, 0.0210.607).Conclusion: Our findings revealed significant associations between insulin resistance and hepatic fibrosis.

🔖

Bu Makaleye Atıf Yap

DÖKMECİ, A., ÜSTÜNDAĞ, Y., HÜLAGÜ, S., TUNCER, İ., AKDOĞAN, M., DEMİRSOY, H., KÖKLÜ, S., GÜZELBULUT, F., DOĞAN, İ., DEMİR, A., AKARSU, M., YÜCEYAR, H., ÖZDOĞAN, O. C., ÖZDENER, F., ERDOĞAN, S. (2014). The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 5, 546–552. https://ajindex.com/articles/410758

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Re- view of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
  2. Simonetti RG, Cammà C, Fiorello F, et al. Hepatitis C virus infec- tion as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97-102.
  3. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9. Negro F. Mechanisms of hepatitis C virus-related insulin resis- tance. Clin Res Hepatol Gastroenterol 2011; 35: 358-63.
  4. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
  5. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-23.
  6. Kukla M, Mazur W, Buldak RJ, et al. Potential role of leptin, adipo- nectin and three novel adipokines - visfatin, chemerin and vaspin - in chronic hepatitis. Mol Med 2011; 17: 1397-410.
  7. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol. Hepatology 2002; 36: 729-36.
  8. Mohamed HR, Abdel-Azziz MY, Zalata KR, Abdel-Razik AM. Rela- tion of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection. Int J Health Sci (Qassim) 2009; 3: 177-86.
  9. Ratziu V, Munteanu M, Charlotte F, Bonyhay L, Poynard T; LIDO Study Group. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol 2003; 39: 1049-55.
  10. Kawaguchi T, Sata M. Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. World J Gastroenterol 2010; 16: 1943-52.
  11. Lecube A, Hernández C, Genescà J, Simó R. Proinflammatory cy- tokines, insulin resistance, and insulin secretion in chronic hepati- tis C patients: A case-control study. Diabetes Care 2006; 29: 1096- 101. Lecube A, Hernández C, Genescà J, Simó R. Glucose abnormali- ties in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Diabetes Care 2006; 29: 1140-9.
  12. Aksu HSZ, Kurtaran B, Onlen Y, et al. Association of insulin re- sistance, viral load, and adipokine levels with liver histology in patients with chronic hepatit